printer-friendly

Sample Business Contracts

Sponsored Research Agreement [Amendment No. 1] - Children's Hospital and EntreMed Inc.

Sponsored Links

                    AMENDMENT TO SPONSORED RESEARCH AGREEMENT

       This is the first Amendment, signed on December 6, 2000 (hereinafter the
"Effective Date of the Amendment"), to the Sponsored Research Agreement dated
June 24, 1999 (hereinafter "the AGREEMENT", attached as Exhibit B to this
Amendment) by and between CHILDREN'S HOSPITAL, a corporation organized and
existing under the laws of the Commonwealth of Massachusetts and having its
principal place of business at 300 Longwood Avenue, Boston, MA 02115
(hereinafter "HOSPITAL"), and ENTREMED, INC., a corporation organized and
existing under the laws of Delaware, and having its principal place of business
at 9640 Medical Center Drive, Rockville, MD 20850 (hereinafter "ENTREMED").

HOSPITAL and ENTREMED mutually desire to amend the AGREEMENT as follows:

       I.     All capitalized terms herein are defined as in the AGREEMENT,
              unless otherwise specified herein.

       2.     In Paragraph 1(a) of the AGREEMENT, "Exhibit A" is replaced with
              "Amended Exhibit A", which Amended Exhibit A is attached hereto as
              Exhibit A to this Amendment.

       3.     In Paragraph 2(a) of the AGREEMENT, "September 29, 2000" is
              replaced with "September 29, 2001".

       4.     Paragraphs 4(a) and (b) of the AGREEMENT are amended to add the
              following sentence to each respective paragraph:

              (a)    In addition, EntreMed agrees to pay Hospital One Million
                     Five Hundred Thousand Dollars ($1,500,000) to fund the
                     Program in accordance with the conditions and terms of this
                     Agreement, as amended.

              (b)    In addition, on October 4, 2000, EntreMed will pay Hospital
                     the sum of $750,000 and thereafter will make one additional
                     payment of $750,000 on March 29, 2001 in accordance with
                     the conditions and terms set forth herein.

       5.     Paragraph 7(b) of the AGREEMENT is deleted and the following
              Paragraph 7(b) is substituted therefor:

              (b)    Hospital shall apply for, seek prompt issuance of, and
                     maintain during the term of this Agreement the patent
                     applications and patents covering Inventions and
                     jointly-owned inventions. Hospital shall solicit EntreMed's
                     comment prior to filing of patent applications and prior to
                     any significant actions required during such filing,
                     prosecution, and maintenance and shall provide EntreMed
                     with drafts of responses sufficiently in advance to allow
                     time for comment and with file copies




<PAGE>   2


                     after the action is completed. Significant actions shall
                     include Hospital's submission of patent applications, all
                     official actions from the patent office and all responses
                     to official actions. Hospital agrees to seriously consider
                     EntreMed's comments with regard to patent prosecution. If
                     Hospital decides not to file, not to continue prosecution
                     or not to maintain any patent application or patent
                     covering Inventions and jointly-owned inventions in any
                     jurisdiction, the Intellectual Property Office of Hospital
                     will notify EntreMed in a timely fashion. Following receipt
                     of any such notice from the Intellectual Property Office of
                     Hospital, EntreMed may thereafter elect to file, continue
                     prosecution, or maintain the patent application or patent
                     that is the subject of such notice, at its own expense and
                     in the name of Hospital. EntreMed shall solicit Hospital's
                     comment prior to the filing of patent applications and
                     prior to any significant actions required during such
                     filing, prosecution, and maintenance and shall provide
                     Hospital with drafts of responses sufficiently in advance
                     to allow time for comment and with file copies after the
                     action is completed. Significant actions shall include
                     EntreMed's submission of patent applications, all official
                     actions from the patent office and all responses to
                     official actions, EntreMed agrees to seriously consider
                     Hospital's comments with regard to patent prosecution.
                     Payment of all reasonable fees and costs incurred by
                     Hospital relating to the filing, prosecution, and
                     maintenance of the patent applications and patents covering
                     Inventions and jointly-owned inventions shall be the
                     responsibility of EntreMed. If EntreMed elects not to pay
                     any such fees and costs with respect to any patent
                     application or parent in any jurisdiction, Hospital shall
                     have the right to file, continue prosecution or maintain
                     such patent application or patent in such jurisdiction at
                     its own expense as it deems necessary and EntreMed shall
                     have no further option or other rights to such patent
                     application or patent in such jurisdiction.

       6.     In Exhibit B to the AGREEMENT (the Model License Agreement),
              Sections 1.4.3, 1.4.4 and 1.4.5 shall be deleted and the following
              sections are substituted therefor:

              1.4.3. Claims of U.S. and foreign continuation-in-part
                     applications, and of the resulting patents, which are
                     directed to subject matter that is described in the U.S.
                     and foreign applications listed in Appendix A in a manner
                     that meets the requirements of 35 U.S.C. Section 112;

              1.4.4. Claims of all later filed foreign patent applications, and
                     of the resulting patents, which are directed to subject
                     matter that is described in the U.S. patents and/or patent
                     applications listed in Appendix A in a manner that meets
                     the requirements of 35 U.S.C. Section 112;

              1.4.5  Any reissues of United States patents described in
                     paragraphs 1.4.1,

<PAGE>   3


                     1.4.21.4.3 and 1.4.4 above.

       7.     In Exhibit B to the AGREEMENT, in Sections 4.6 and 5.4,
              "BankBoston" is replaced with "FleetBoston Financial".

       8.     Also in Exhibit B to the AGREEMENT, Sections 6.1 and 6.2 shall be
              deleted and the following sections are substituted therefor:

              6.1    Hospital shall apply for, seek prompt issuance of, and
                     maintain during the term of this Agreement the patent
                     applications and patents covering Inventions and
                     jointly-owned inventions. Hospital shall solicit EntreMed's
                     comment prior to filing of patent applications and prior to
                     any significant actions required during such filing,
                     prosecution, and maintenance and shall provide EntreMed
                     with drafts of responses sufficiently in advance to allow
                     time for comment and with file copies after the action is
                     completed. Significant actions shall include Hospital's
                     submission of patent applications, all official actions
                     from the patent office and all responses to official
                     actions. Hospital agrees to seriously consider EntreMed's
                     comments with regard to patent prosecution. If Hospital
                     decides not to file, not to continue prosecution or not to
                     maintain any patent application or patent covering
                     Inventions and jointly-owned inventions in any
                     jurisdiction, the Intellectual Property Office of Hospital
                     will notify EntreMed in a timely fashion. Following receipt
                     of any such notice from the Intellectual Property Office of
                     Hospital, EntreMed may thereafter elect to file, continue
                     prosecution, or maintain the patent application or patent
                     that is the subject of such notice, at its own expense and
                     in the name of Hospital. EntreMed shall solicit Hospital's
                     comment prior to the filing of patent applications and
                     prior to any significant actions required during such
                     filing, prosecution, and maintenance and shall provide
                     Hospital with drafts of responses sufficiently in advance
                     to allow time for comment and with file copies after the
                     action is completed. Significant actions shall include
                     EntreMed's submission of patent applications, all official
                     actions from the patent office and all responses to
                     official actions, EntreMed agrees to seriously consider
                     Hospital's comments with regard to patent prosecution.
                     Payment of all reasonable fees and costs incurred by
                     Hospital relating to the filing, prosecution, and
                     maintenance of the patent applications and patents covering
                     Inventions and jointly-owned inventions shall be the
                     responsibility of EntreMed. If EntreMed elects not to pay
                     any such fees and costs with respect to any patent
                     application or patent in any jurisdiction, Hospital shall
                     have the right to file, continue prosecution or maintain
                     such patent application or patent in such jurisdiction at
                     its own expense as it deems necessary and EntreMed shall
                     have no further option or other rights to such patent
                     application or patent in such jurisdiction.

<PAGE>   4


              6.2    Payment of all reasonable fees and costs relating to the
                     filing, prosecution, and maintenance of the patent
                     applications and patents included in Patent Rights shall be
                     the responsibility of Licensee, whether such fees and costs
                     were incurred before or after the date of this Agreement.
                     If Licensee elects not to pay for any such fees and costs
                     with respect to any patent application or patent included
                     in Patent Rights in any jurisdiction, CMCC shall have the
                     right to file, continue prosecution or maintain such patent
                     application or patent in such jurisdiction at its own
                     expense as it deems necessary and Licensee shall have no
                     further rights to such patent application or patent in such
                     jurisdiction.

       9.     The provisions of this Amendment are expressly incorporated in the
              AGREEMENT.

       10.    Any conflict between a provision in this Amendment and a provision
              in the AGREEMENT shall be resolved in favor of the provision of
              this Amendment.

       11.    This Amendment shall be deemed effective as of the Effective Date
              of the Amendment.

       12.    This Amendment may be signed in counterparts, each of which shall
              be considered an original, but all of which shall constitute one
              and the same instrument.


<PAGE>   5


       In Witness whereof, HOSPITAL and ENTREMED have caused this Amendment to
be executed on the dates indicated below:

For CHILDREN'S HOSPITAL:

Name: /s/ JAMES MANDELL
     ----------------------------------------
Title: President and Chief Executive Officer
      -------------------------------------------

Date:  December 6, 2000


For ENTREMED, INC.:

Name: /s/ JOHN HOLADAY
     ----------------------------------------
Title: Chairman and CEO
      -------------------------------------------

Date:  December 5, 2000



Name: /s/ JUDAH FOLKMAN, MD.
     --------------------------------------------
Title: Judah Folkman, M.D. Principal investigator

Date:  December 7, 2000